An analytical comparison of cobalt cardiomyopathy and idiopathic dilated cardiomyopathy

被引:11
作者
Centeno, JA
Pestaner, JP
Mullick, FG
Virmani, R
机构
[1] ARMED FORCES INST PATHOL,DEPT CARDIOVASC PATHOL,WASHINGTON,DC 20306
[2] OFF CHIEF MED EXAMINER,NEW YORK,NY
关键词
dilated cardiomyopathy; toxic cardiomyopathy; cobalt;
D O I
10.1007/BF02784165
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toxic cardiomyopathy (TC) has a rapid clinical course and morphologically resembles idiopathic dilated cardiomyopathy (IDC). To further characterize TC, we used light microscopy to compare lesions caused by cobalt (Go) to those of IDC. Cobalt levels were also measured as a chemical marker to differentiate TC from IDC. We reviewed cases with TC and IDC and excluded all cases with chemotherapy-induced myopathy and catecholamine toxicity as well as cases with possible infectious, ischemic, or hypersensitivity-induced myopathies. We compared the light microscopic findings of 12 TC cases to 12 cases of IDC, and measured trace Co levels on digested heart tissue samples. The TC cases had prominent myofibrillar loss and atrophy; no cases had neutrophil infiltration or frank myocyte necrosis. In contrast, IDC had minimal myofibril loss and atrophy. Cobalt levels in the range of 0.6 to 5.45 mu g/g of dry tissue were obtained for the TC cases, while IDC demonstrated Co levels of 0.01-0.2 mu g/g. Distinction between TC and IDC is predominantly a function of myocyte change, with TC showing myofibrillar loss and atrophy in the absence of inflammatory infiltrates and fibrosis; IDC is predominantly associated with myocyte hypertrophy, atrophy, and fibrosis.
引用
收藏
页码:21 / 30
页数:10
相关论文
共 50 条
[21]   Allograft Pathology in Patients Transplanted for Idiopathic Dilated Cardiomyopathy [J].
Zhang, Mingchang ;
Tavora, Fabio ;
Huebner, Thomas ;
Heath, Jonathan ;
Burke, Allen .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) :389-395
[22]   The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy [J].
Mobini, Reza ;
Andersson, Bert .
FUTURE CARDIOLOGY, 2005, 1 (05) :675-682
[23]   Molecular evaluation of enteroviruses in the pathogenesis of idiopathic dilated cardiomyopathy [J].
Jeffery, S ;
Kelling, PJ ;
Lukaszyk, A ;
Boriskin, YS ;
Booth, JC ;
Hodgson, J ;
Davies, MJ ;
McKenna, WJ .
CLINICAL CARDIOLOGY, 1997, 20 (10) :857-863
[24]   Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy [J].
Bäumer, AT ;
Flesch, M ;
Wang, XK ;
Shen, QC ;
Feuerstein, GZ ;
Böhm, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (01) :121-130
[25]   Prevalence of Celiac Disease in Children with Idiopathic Dilated Cardiomyopathy [J].
Zahmatkeshan, Mozhgan ;
Fallahpoor, Mahsa ;
Amoozgar, Hamid .
IRANIAN JOURNAL OF PEDIATRICS, 2014, 24 (05) :587-592
[26]   Vitamin D Status in Children with Idiopathic Dilated Cardiomyopathy [J].
Raafat, Duaa M. ;
EL-Asheer, Osama M. ;
Mahmoud, Amal A. ;
Darwish, Manal M. ;
Osman, Naglaa S. .
JOURNAL OF CHILD SCIENCE, 2021, 11 (01) :E120-E124
[27]   Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy A Report From the Pediatric Cardiomyopathy Registry Study Group [J].
Rusconi, Paolo ;
Wilkinson, James D. ;
Sleeper, Lynn A. ;
Lu, Minmin ;
Cox, Gerald F. ;
Towbin, Jeffrey A. ;
Colan, Steven D. ;
Webber, Steven A. ;
Canter, Charles E. ;
Ware, Stephanie M. ;
Hsu, Daphne T. ;
Chung, Wendy K. ;
Jefferies, John L. ;
Cordero, Christina ;
Lipshultz, Steven E. .
CIRCULATION-HEART FAILURE, 2017, 10 (02)
[28]   What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, dilated cardiomyopathy study [J].
Coughlin, SS ;
Myers, L ;
Michaels, RK .
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1997, 89 (04) :277-282
[29]   Dilated cardiomyopathy [J].
Ehlermann P. ;
Katus H.A. .
Herzschrittmachertherapie + Elektrophysiologie, 2012, 23 (3) :196-200
[30]   DILATED CARDIOMYOPATHY [J].
DUSLEAG, J .
MEDIZINISCHE WELT, 1995, 46 (10) :466-475